Quest Diagnostics (DGX) Tops Q2 EPS by 2c, Beats on Revenue; Offers FY24 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Quest Diagnostics (NYSE: DGX) | Delayed: 255.68 +8.62 (3.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $247.06 | 52 Week High | $86.85 | |||
| Open | $250.61 | 52 Week Low | $59.66 | |||
| Day High | $255.81 | P/E | 48.15 | |||
| Day Low | $247.39 | EPS | $5.31 | |||
| Volume | 915,715 | |||||
